Bluebee raises €10m series-A from Capricorn et al.

Bluebee's existing shareholders, including Buysse & Partners and the management team, also joined the financing round.

According to a statement, the fresh capital will support the product's development and the company's expansion in both Europe and the US. According to Capricorn investment manager Marc Lambrechts, the investors will also consider strategic acquisitions to expand the business.

As part of the deal, Bluebee appointed a new chairman to its board of advisers: Annie Vereecken, the founder and former owner of the AML-Labo Riatol labs.

Capricorn invested through its Capricorn ICT Fund, which held a final close on €33.2m in October 2014. The vehicle focuses on the igital healthcare and big data sectors.

Company
Founded in 2011 as a spin-off of the Delft University of Technology and Imperial College London, Bluebee offers a cloud-based software and an accelerated hardware for genomic data analysis, which forms the core of DNA analysis.

Bluebee is co-headquartered in Delft, the Netherlands, and in Mechelen, Belgium. The business has clients in Europe and in the US and employs 20 people.

People
Capricorn Venture - Marc Lambrechts (senior investment manager).
Korys - Vincent Vliebergh (CEO).
Bluebee - Hans Cobben (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• Technology
• Healthcare
• Benelux
• Netherlands
• Belgium
• Venture